• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. MEMO 3D RECHORD SEMIRIGID ANNULOPLASTY RING; MITRAL ANNULOPLASTY RING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. MEMO 3D RECHORD SEMIRIGID ANNULOPLASTY RING; MITRAL ANNULOPLASTY RING Back to Search Results
Model Number MRCS28
Device Problem Detachment of Device or Device Component (2907)
Patient Problems Dyspnea (1816); Fatigue (1849); Mitral Insufficiency (1963)
Event Date 08/22/2019
Event Type  Injury  
Event Description
On (b)(6) 2019, a mitral valve repair with a memo 3d-rechord was performed.The implant of the ring was performed using the horizontally mattressed 2-0 ticron circumferentially.During the same surgery, three other concomitant procedures occurred: a tricuspid valve replacement with a 33mm edwards bioprosthesis, and a bi-atrial maze procedure, with ablation of both the anterior and posterior mitral trigones; a ligation of the left atrial appendage.An initial normal postoperative course was reported.The patient was seen in by a cardiologist for follow up visit on (b)(6) 2019.Low k level was noticed.The patient was consequently sent to ed on (b)(6) 2019 for further workup, and posterior ring dehiscence was noticed on the echo.The diagnosis was: hypokalemia, acute on chronic congestive heart failure, unspecified heart failure type.Currently, the patient presents severe mitral regurgitation and is very symptomatic with dyspnea, fatigue, orthopnea, and nocturnal desaturation. the patient was evaluated for a mitraclip but was found not to be a candidate due to insufficient access to leaflets.A re-do sternotomy and bioprosthetic mvr is planned, but no re-intervention has been performed yet.Based on the physician's assessment, a potential contributory factor to the reported dehiscence could be identified in the stitching area, which was reportedly very thin.
 
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Since the device was not explanted, no device inspection can be performed at this time.Based on the information available, it is not possible to establish the root cause of the event.However, based on the document review, no manufacturing nor quality deficits were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEMO 3D RECHORD SEMIRIGID ANNULOPLASTY RING
Type of Device
MITRAL ANNULOPLASTY RING
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia, vercelli
MDR Report Key9137666
MDR Text Key161961525
Report Number1718850-2019-01095
Device Sequence Number1
Product Code KRH
UDI-Device Identifier08022057015075
UDI-Public(01)08022057015075(240)ICV1332(17)231016
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup
Report Date 09/04/2019,11/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/16/2023
Device Model NumberMRCS28
Device Catalogue NumberICV1332
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date09/04/2019
Device Age10 MO
Event Location Hospital
Date Report to Manufacturer09/04/2019
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/30/2019
Supplement Dates Manufacturer Received09/04/2019
Supplement Dates FDA Received11/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age68 YR
-
-